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Blood coagulation activity in humans increases with advancing age. This is 
apparently due to the age-related increase in disparity between pro-coagulant and 
anticoagulant activities, and may contribute to thrombosis and cardiovascular 
diseases in elderly. Recently we reported the first age-related regulatory 
mechanisms of gene expression and its fundamental universality (Science 1999; 
285: 739-43; J. Biol. Chem. 2002; 277: 4532-40) using human factor IX (hFIX) and 
anticoagulant human protein C (hPC) gene. We showed that ASE is essential for the 
age-related stability of hFIX and hPC gene expression and AIE is essential for age-
related increase of hFIX gene (hPC gene lacks AIE). We also showed that the 
conversion from the age-stable pattern of hPC gene expression to age-increase 
pattern can be done with AIE.
Here we tested whether or not the age-related regulatory mechanisms universally 
function with totally unrelated, heterologous genes. A set of hFIX minigene 
expression vectors with a CMV promoter with and without ASE were constructed. 
These constructs showed similar transient expression activities in HepG2 cells. 
However, transgenic mice carrying these minigenes showed markedly different 
expression patterns. Animals carrying hFIX minigene without ASE showed age-
unstable decline in hFIX expression in 8-9 months of age. In contrast, minigenes 
with ASE showed stable expression over 10 months of age (end of experiment). 
These results successfully supported that the age-regulatory mechanisms, which 
were originally found with blood coagulation factor genes, function with the CMV 
promoter. Animal testing of ASE and AIE combination in animals is in progress.
These observations lead us to developing Age Dimension Technology (ADT), a novel 
field of applications of new knowledge obtained through these studies.
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